Numerous contenders—from a controversial malaria medication to treatments that regulate the immune system; Chloroquine and Hydroxychloroquine, Remdesivir, Ritonavir and lopinavir, tocilizumab— and convalescent plasma are against COVID-19 in clinical trials. However, some answers can be expected in the next few weeks and months as the results of clinical trials emerge.